Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 9, 2015 - Issue 1
Submit an article Journal homepage
372
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Fluticasone furoate and vilanterol inhalation powder for the treatment of chronic obstructive pulmonary disease

Maria Gabriella MateraDepartment of Experimental Medicine, Section of Pharmacology ‘L. Donatelli’, Centre of Excellence for Cardiovascular Diseases, Second University of Naples, Naples, ItalyCorrespondence[email protected]
,
Annalisa CapuanoDepartment of Experimental Medicine, Section of Pharmacology ‘L. Donatelli’, Centre of Excellence for Cardiovascular Diseases and Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Second University of Naples, Naples, Italy
&
Mario CazzolaDepartment of System Medicine, Unit of Respiratory Clinical Pharmacology, University of Rome Tor Vergata, Roma, Italy
Pages 5-12 | Published online: 06 Dec 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Mario Cazzola, Paola Rogliani, Luigino Calzetta, Josuel Ora & Maria Gabriella Matera. (2022) A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD. Expert Review of Clinical Pharmacology 15:3, pages 269-283.
Read now
Timothy E Albertson, Susan Murin, Mark E Sutter & James A Chenoweth. (2017) The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials. Pragmatic and Observational Research 8, pages 175-181.
Read now
Vicky Chang, Emma L. Gray & Paul S. Thomas. (2016) Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma. Expert Review of Respiratory Medicine 10:10, pages 1069-1078.
Read now

Articles from other publishers (2)

Bryony Coupe, Andrew L. Griffiths & Gwyneth A. Davies. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 153 164 .
Shuguang Hou, Jiangyue Wu, Xu Li & Hong Shu. (2015) Practical, regulatory and clinical considerations for development of inhalation drug products. Asian Journal of Pharmaceutical Sciences 10:6, pages 490-500.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.